Mereo BioPharma said a US healthcare investor had bought a stake in the company for $3m. The investor had bought around 12.3m shares at 18.8p each, a 20% discount to Mereo's closing share price on Tuesday. Mereo said it would use the proceeds for general corporate purposes, including clinical trial activity and working capital. At 8:41am: (LON:MPH) Mereo Biopharma Group Ltd share price was +0.5p at 24p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.